• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Transgenomic Inc. (TBIO)

    -NasdaqCM
    3.74 Down 0.16(4.10%) Jan 30, 4:00PM EST
    |After Hours : 3.95 Up 0.21 (5.61%) Jan 30, 4:05PM EST
    Add to Portfolio
    Prev Close:3.90
    Open:3.94
    Bid:N/A
    Ask:3.79 x 600
    1y Target Est:10.00
    Beta:0.66
    Next Earnings Date:N/A
    Day's Range:3.46 - 4.00
    52wk Range:1.41 - 6.20
    Volume:165,408
    Avg Vol (3m):64,053
    Market Cap:30.23M
    P/E (ttm):N/A
    EPS (ttm):-1.79
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TBIO

    Comparison

    Symbol% ChgMkt Cap
    TBIODown 4.10%30.23M
    DGXDown 0.03%10.23B
    RHHBYDown 1.79%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.23
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.80
    Quarterly EPS Est (Dec-14) :-0.56
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.06

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Transgenomic, Inc. operates as a biotechnology company that focuses advancing personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and clinical and research services i... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback